UBS raised the firm’s price target on Eastman Chemical to $93 from $91 and keeps a Neutral rating on the shares. The company’s Q4 results were in line and its initial guidance for FY24 was a “slight miss”, though it is likely nearing the end of the worst of volume declines, the analyst tells investors in a research note. UBS adds that Eastman Chemical’s guide is likely “credible” and that the company’s earnings should lift as destocking abates and as production normalizes to demand.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EMN:
- EMN Upcoming Earnings Report: What to Expect?
- RBC would be buyers amid today’s DuPont selloff
- Eastman Chemical price target raised to $101 from $95 at KeyBanc
- Eastman Chemical price target raised by $11 at Citi, here’s why
- Eastman Chemical raises quarterly dividend to 81c from 79c per share
Questions or Comments about the article? Write to editor@tipranks.com